ASSESSMENT OF SOCIAL AND ECONOMIC DAMAGE ASSOCIATED WITH MORTALITY FROM RESPIRATORY CANCER IN THE TOMSK REGION (2005–2016)

Introduction. A significant component in the system analysis of anti-cancer activities is the assessment of the impact of mortality on life expectancy, which indicates the social and economic situation in the region.

Material and methods. The economic damage caused by laryngeal and lung cancer mortality in the Tomsk region for the period 2005–2016 was analyzed using the database of the regional cancer registry and local agency of federal state statistics service of the tomsk region.

Results. The loss of the male working population ranged from 106.0 (2012–2013) to 161.5 (2008–2009) person/years of lifetime from larynx cancer and from 1058.5 (2013–2014) to 1576.3 (2006–2007) person/years of lifetime from lung cancer. The female working population lost up to 34.0 (2013–2014) person/years of lifetime due to mortality from larynx cancer and from 1445.3 (2005–2006) to 2553.9 (2015–2016) person/years of lifetime from lung cancer. The average number of undelivered years in working age due to the premature death of one man averaged 6.1 ± 2.0 years from larynx cancer and 11.1 ± 1.3 from lung cancer, one woman averaged 4.6 ± 0.9 years from larynx cancer and 6.2 ± 0.3 years from lung cancer. Economic losses associated with mortality from cancer of the respiratory system amounted to 2.251.97 million rubles: 202.07 million rubles from laryngeal cancer and 2.049.90 million rubles from lung cancer.

Conclusion. The quantitative analysis of social and economic losses associated with mortality from cancer of the respiratory system enables the regional health authorities to develop and implement anti-cancer interventions to maximize the use of funds for the prevention, treatment and rehabilitation of cancer patients.

1. Zhigulev A.N., Mishlanov V.Yu., Orlov O.A., Katkova A.V. Selected demographic indicators, risk factors and current trends in screening for malignant neoplasms (Literature review). Practical Oncology. 2018; 19 (1): 46–57. (in Russian).

2. Afanas’eva L.N., Gol’derova A.S., Burnasheva L.S., Nikolaeva T.I., Myreeva S.A., Vinokurov M.M., Makarova N.N., Ivanov P.M. Malignant neoplasms as the most important socio-economic problem in the North. Yakut Medical Journal. 2019; 4: 6–10. (in Russian). doi: 10.25789/YMJ.2019.68.01.

3. GLOBOCAN 2018. Global Cancer Observatory. International Agency for Research on Cancer 2018 [Internet]. URL: http://gco.iarc.fr/tomorrow/graphic-bar (Cited 17.04.2019).

4. Kaprin A.D., Starinskij V.V., Petrova G.V. Malignant neoplasms in Russia in 2018 (morbidity and mortality). Moscow, 2019. 250 р. (in Russian).

5. Choynzonov E.L., Zhuikova L.D., Odintsova I.N. Mortality from respiratory system cancer in the Tomsk region. Siberian Journal of Oncology.2018; 17 (3): 5–10. (in Russian). doi: 10.21294/1814-4861-2018-17-3-5-10.

6. Choynzonov E.L., Pisareva L.F., Zhuikova L.D., Ananina O.A., Odincova I.N. Incidence of respiratory system cancer in the Tomsk region (2005–2016). Problems in Oncology. 2018; 64 (6): 732–738. (in Russian). doi: 10.37469/0507-3758-2018-64-6-732-738.

7. Choinzonov E.L., Pisareva L.F., Zhuikova L.D. Odintsova I.N., Ananina O.A. Larynx cancer in the Tomsk region: assessment of cancer care based on survival rates (2004–2013). Problems in Oncology. 2014; 60(6): 683-686. (in Russian). doi: 10.18722/VO2014606683-686.

8. The losses of the Russian economy from deaths due to cancer were estimated at $8 billion per year [Internet]. URL: https://www.rbc.ru/rbcfreenews/5d482a1d9a7947af6f27cb94 (cited: 05.08.2019). (in Russian).

9. Yumov E.L., Tsyganov M.M., Litvyakov N.V., Polishchuk T.V., Miller S.V., Rodionov E.O., Tuzikov S.A. Expression of genes for multidrug resistance and mono-resistance in non-small cell lung cancer. Siberian Journal of Oncology. 2014; 1: 16–22. (in Russian).

10. Dmitrieva A.I., Novitski V.V., Sevostjanova N.V., Freidin M.B., Pusyrev V.P., Kolomiets S.A., Cheremisina O.V., Nerush E.V., Ten L.A. Study of polymorphism of GSTTl and GSTMl genes in lung cancer patients. Herald of Siberian Branch of Russian Academy Medical Sciences. 2004; 24 (1): 60–62. (in Russian).

11. Merabishvili V.M., Arsen’ev A.I., Tarkov S.A., Barchuk A.A., Shcherbakov A.M., Demin E.V., Merabishvili E.N. Morbidity and mortality of the population from lung cancer, the accuracy of the registration. Siberian Journal of Oncology. 2018; 17 (6): 15–26. (in Russian). doi: 10.21294/1814-4861-2018-17-6-15-26.

12. Aksarin A.A., Ter-Ovanesov M.D., Bilan E.V. Modern approaches to the surgical treatment of non-small cell lung cancer. Medical alphabet. 2017; 2 (25): 54–57. (in Russian).

13. Skripchak Yu.V., Kononova G.V., Asakhin S.M., Levit M.L., Pushkareva I.K., Val’kov M.Yu. Radiation therapy for small cell lung cancer: evolution, current state, prospects. Siberian Journal of Oncology. 2011; 6: 74–82. (in Russian).

14. Sapunova I.D., Kontsevaya A.V., Myrzamatova A.O., Mukaneeva D.K., Khudyakov M.B., Ipatov P.V., Drapkina O.M. Economic damage from smoking associated with four groups of chronic noncommunicable diseases in the Russian Federation in 2016. Cardiovascular Therapy and Prevention. 2019; 18 (6): 6–12. (in Russian). doi: 10.15829/1728-8800-2019-6-6-12.

15. Amlaev K.R., Koychuev A.A., Makhov Z.D., Koychueva S.M. Lung and Breast Cancer: Epidemiological, Diagnostic, Rehabilitation Aspects (Review). Scientific thought of Caucasus. 2012; 4: 103–110. (in Russian).

16. Morozova O.A., Zakharenkov V.V., Viblaya I.V., Morozov V.P. Risk factors for the development and natural history of lung cancer in persons under the age of 50. Medicine in Kuzbass. 2014; 13 (2): 27–31. (in Russian).

17. Safontsev I.P., Zukov R.A., Modestov A.A., Slepov E.V., Son I.M., Laricheva I.V. The role of screening in the management of lung cancer epidemiology in the Krasnoyarsk Territory. Problems in Oncology. 2017; 63 (3): 385–393. (in Russian)]

18. Gordienko V.P., Vakhnenko A.A., Ekoniya D.T. Cancer of the trachea, bronchi and lung in the Far Eastern Federal District. Bulletin Physiology and Pathology of Respiration. 2019; 71: 71–79. (in Russian). doi: 10.12737/article_5c89a5ae3f5443.13929986.

19. Shmatova Yu.E. The cost of mortality from malignant neoplasms: a regional aspect (on the example of the Vologda region). Journal of Oncology. 2015; 9 (1): 5–12. (in Russian).

20. Aksel’ E.M., Dvoyrin V.V., Trapeznikov N.N. Statistics of malignant tumors (incidence, mortality, trends, socio-economic damage, life expectancy). Moscow, 1992. 308 p. (in Russian).

21. Petrova G.V., Gretsova O.P, Kaprin A.D., Starinskii V.V. Characteristics and methods of calculating medical and statistical indicators used in oncology. Moscow, 2014. 40 р. (in Russian).

22. Volume and dynamics of the gross regional product. Federal State Statistics Service of the Russian Federation [Internet]. URL: http://tmsk.gks.ru/wps/wcm/connect/rosstat_ts/tmsk/ru/statistics (cited 2019 Feb 3). (in Russian).

23. Tikhomirova A.V. Drug supply for patients with lung cancer in the Russian Federation. Modern Organization of Drug Supply. 2014; 2: 30–50. (in Russian).

24. Laktionov K.K. The financial burden of the state of modern treatment of lung cancer [Internet]. URL: http://oncology-association.ru/files/lectures/laktionov.pdf (cited 05.08.2019). (in Russian).

25. Amlaev K.R., Koychuev A.A. Makhov Z.D., Koychueva S.M., Khurtsev K.V. Results of studying some aspects of cancer prevention and the quality of life of cancer patients. Kuban Scientific Medical Bulletin. 2013; 5: 21–25. (in Russian).

26. Nikitina E.N., Kiseleva E.A. Technological management of carcinogenic risks in industry – strategy and tactics. Ecology of industrial production. 2018; 4: 26–31. (in Russian).

27. Petrova G.V., Starinskiy V.V., Gretsova O.P., Shakhzadova A.O., Samsonov Yu.V. The state of cancer care to the population of Russia in 2017 according to federal statistical observation. P.A. Herzen Journal of Oncology. 2019; 1: 32–40. (in Russian). doi: 10.17116/onkolog2019801132.

28. Choynzonov Ye.L., Balatskaya L.N., Dubskiy S.V., Chizhevskaya S.YU., Kupriyanova I.Ye., Krasavina Ye.A., Tuzikov S.A., Polishchuk T.V., Popov D.N., Zhogina ZH.A., Musabayeva L.I., Slonimskaya Ye.M., Bekher O.A., Kolomiyets L.A., Churuksayeva O.N., Molchanov S.V., Zhuykova L.D. Quality of life in cancer patients. Tomsk, 2011; 120–138. (in Russian)